Search

Search Constraints

You searched for: Author/Creator Wu, Dauh-Rurng

Search Results

1. Annulation reaction enables the identification of an exocyclic amide tricyclic chemotype as retinoic acid Receptor-Related orphan receptor gamma (RORγ/RORc) inverse agonists. Issue 19 (1st October 2020)

2. BMS-871: A novel orally active pan-Notch inhibitor as an anticancer agent. Issue 9 (1st May 2015)

3. BMS-871: A novel orally active pan-Notch inhibitor as an anticancer agent. Issue 9 (1st May 2015)

4. Discovery of (3S, 4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonists. Issue 17 (1st September 2020)

5. Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymerase. Issue 15 (1st August 2017)

6. Enantioselective synthesis of BMS-911278: a triple reuptake inhibitor. Issue 1 (15th January 2017)

7. Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity. Issue 2 (15th January 2018)

8. Identification of potent tricyclic prodrug S1P1 receptor modulators12. Issue 4 (1st December 2016)

9. Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists. Issue 16 (15th August 2019)

10. Tricyclic sulfones as potent, selective and efficacious RORγt inverse agonists – Exploring C6 and C8 SAR using late-stage functionalization. Issue 23 (1st December 2020)